The MHC in human bone marrow allotransplantation
- PMID: 6227438
- DOI: 10.1016/s0308-2261(83)80004-6
The MHC in human bone marrow allotransplantation
Abstract
In this chapter, we have considered the theoretical and practical background of bone marrow transplantation. The immune response and its regulation by genes within the major histocompatibility complex, particularly of the I region of the mouse and of the HLA-D/DR region in man, is of central importance in both graft acceptance (rejection) and graft-versus-host disease. Methods which are available for typing alleles at the HLA-A, -C, -B, -DR and complotype (BF, C2, C4A, C4B) loci, have been considered in detail. The extent to which recombination affects specific alleles on haplotypes within families is discussed, as is the occurrence of linkage disequilibrium and extended haplotypes in populations of unrelated individuals. Because the HLA-DR and complotype region in man is thought to be critical for the success of bone marrow transplantation, methods for typing of HLA-D by both the HTC and PLT approaches have been examined. Although HLA-D/DR assignments are easily made in normal subjects, they are ambiguous in about 50 per cent of candidates for bone marrow transplantation, including, particularly, patients with aplastic anaemia, leukaemia, and severe combined immunodeficiency. In this setting, it is particularly important to obtain additional information by modification of HLA-D typing procedures and through complotype and GLO allele determinations in all family members. Finally, we can hope that there will be an increased possibility of using non-family donors through methods for removing cytotoxic T cells from donor marrow and through the identification, in the general population, of individuals who are genotypically similar or identical to the recipient. In this regard, the recognition that some 30 per cent of chromosome 6 in caucasians (50 per cent of individuals) bear extended haplotypes, which include a relatively fixed set of alleles particularly in the HLA-B, -DR, complotype and GLO regions, offers considerable promise.
Similar articles
-
Complotypes, extended haplotypes, male segregation distortion, and disease markers.Hum Immunol. 1986 Apr;15(4):366-73. doi: 10.1016/0198-8859(86)90013-3. Hum Immunol. 1986. PMID: 3516938 Review.
-
Unrelated individuals matched for MHC extended haplotypes and HLA-identical siblings show comparable responses in mixed lymphocyte culture.Lancet. 1985 Oct 19;2(8460):853-6. doi: 10.1016/s0140-6736(85)90123-0. Lancet. 1985. PMID: 2864576
-
Complotypes and extended haplotypes in laboratory medicine.Complement Inflamm. 1989;6(1):8-18. doi: 10.1159/000463067. Complement Inflamm. 1989. PMID: 2650992 Review.
-
Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population.Tissue Antigens. 1988 Jan;31(1):14-25. doi: 10.1111/j.1399-0039.1988.tb02060.x. Tissue Antigens. 1988. PMID: 3341017
-
Complotype genetic loci segregate more frequently with HLA-DR than with HLA-B.Immunogenetics. 1985;21(1):25-31. doi: 10.1007/BF00372238. Immunogenetics. 1985. PMID: 3871424
Cited by
-
Graft versus leukemia in bone marrow transplantation.Blut. 1988 Aug;57(2):57-63. doi: 10.1007/BF00319727. Blut. 1988. PMID: 3044461 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous